MRNX (Defiance Daily Target 2X Long MRNA ETF) Stock Analysis - AI Report

Defiance Daily Target 2X Long MRNA ETF (MRNX) is a publicly traded the market company. As of May 21, 2026, MRNX trades at $27.10 with a market cap of $0 and a P/E ratio of 0.00. MRNX moved -3.43% today. Year to date, MRNX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces MRNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on MRNX?

Rallies AI research for MRNX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

MRNX Key Metrics

Key financial metrics for MRNX
MetricValue
Price$27.10
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume171.29K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest MRNX News

MRNX Analyst Consensus

MRNX analyst coverage data. Average price target: $0.00.

Common questions about MRNX

What is the AI research view on MRNX?
Rallies AI research for MRNX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for MRNX?
Rallies AI research for MRNX combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is MRNX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MRNX. It does not provide personalized investment advice.
MRNX

MRNX